Safety study of TL-001 in healthy adults
This trial tests a new drug, TL-001, in healthy volunteers to see if it is safe and how the body processes it. You may join if you are a healthy adult between 18 and 55.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 55 years old.
- Your body mass index (BMI) must be between 18 and 32, and you need to weigh at least 50 kg (110 lbs) if male or 45 kg (99 lbs) if female.
- You must be generally healthy with no significant medical conditions, as confirmed by a physical exam and lab tests.
- If you are female and could become pregnant, you must use effective birth control and not be pregnant or breastfeeding.
- You must not have used certain medications, supplements, or drugs recently, and you should not smoke more than 5 cigarettes a day.
- You must be able to commit to all study visits and procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new oral medication, TESP-0401, in healthy volunteers to check its safety, how the body processes it, and any side effects. It is a first-in-human trial, so participants help determine if the drug is safe enough for future studies.
This trial tests a new drug called LIFE-001 in healthy volunteers to check its safety and how the body handles it. It is for people without significant health issues.
This early-stage study tests a new experimental drug called LG-0317 in healthy volunteers to see if it is safe and how the body processes it. If you are healthy and meet the basic requirements, this trial may help advance a new treatment option.
This is an early-stage study testing a new drug called TL-003 to see if it's safe and how the body processes it. Researchers will first test it in healthy volunteers, then in people with ulcerative colitis (an inflammatory bowel disease) to understand if it might help reduce inflammation.
This study tests a new medicine called LH-001 in healthy volunteers to see if it is safe. You will receive either the medicine or a placebo (a dummy pill) and stay overnight for monitoring.
This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.
Hear when a new Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.